Trimethoprim-associated hyperkalaemia: a systematic review and meta-analysis.

Pietro B FaréErica MemoliGiorgio TregliaMario G BianchettiGregorio Paolo MilaniPaola MarchisioSebastiano A G LavaSimone Janett

Published in: The Journal of antimicrobial chemotherapy (2022)

The present analysis documents the hyperkalaemic potential of trimethoprim, a widely prescribed drug that was introduced more than 50 years ago. Clinicians must recognize patients at risk of trimethoprim-associated hyperkalaemia.

Keyphrases

palliative care
emergency department
risk assessment
adverse drug